Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. COVID Testing Kits
  6. 22181010

LumiraDx SARS-CoV-2 Surveillance Test

LumiraDx SARS-CoV-2 Ag Surveillance Test Kit (48/Pack) is used in conjunction with the LumiraDx Instrument allowing for users to perform COVID-19 surveillance tests. Up to 5 nasal swab specimens can be pooled for testing, aiding in the surveillance of COVID-19 in populations.

Supplier:  LumiraDx L016000312048

Catalog No. 22-181-010

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

This item is not returnable. View return policy

Description

Description

  • The LumiraDx SARS-CoV-2 Antigen (Ag) Surveillance Tests are used with the LumiraDx Instrument for COVID-19 surveillance testing.
  • With lab-comparable results in 12 minutes, the LumiraDx SARS-CoV-2 Ag Surveillance Test delivers fast, accurate, cost-efficient pooled testing onsite to verify that COVID-19 isn’t spreading in your population or quickly implement preventative measures when clusters emerge.
    • For Surveillance use only*
    • 100.0% positive agreement and 96.6% negative agreement with LumiraDx SARS-CoV-2 Ag Test
    • Up to 5 specimens on a single Test Strip
    • Pooled swab sample may be applied to a single test strip, without sacrificing sensitivity
    • Results in 12 minutes
  • Orders require executed contractual agreement. Please contact your Fisher Healthcare Account Representative for more information
  • *Surveillance Testing is intended to monitor community - or population - level outbreaks of disease, or to characterize the incidence and prevalence of disease. It is performed on de-identified specimens, and thus, results are not linked to individual people. The LumiraDx SARS-CoV-2 Ag Surveillance Test has not been cleared, approved, or authorized by FDA. This test should be used for surveillance purposes (i.e., to inform population or community-level decision-making on de-identified specimens) only. FDA does not regulate surveillance tests.
Specifications

Specifications

Yes
SARS-CoV-2
No
Nasal or Nasopharyngeal Swab Specimens
Surveillance Use Only
12 min.
Not Applicable
Microfluidic Immunofluorescence
Test Strips
96.6% to LumiraDx Ag Test
LumiraDx Instrument
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

Surveillance Testing is intended to monitor community - or population - level outbreaks of disease, or to characterize the incidence and prevalence of disease. It is performed on de-identified specimens, and thus, results are not linked to individual people. The LumiraDx SARS-CoV-2 Ag Surveillance Test has not been cleared, approved, or authorized by FDA. This test should be used for surveillance purposes (i.e., to inform population or community-level decision-making on de-identified specimens) only. FDA does not regulate surveillance tests.